Medicalgorithmics S.A. — Regulatory Filings 2023

Jan 16, 2023

Medicalgorithmics US HoldingCorporation received 3,0 mUSD of the IRS Tax Refund Amount from Medi-Lynx

RB: 2/2023

Date: 16.01.2023

Legal basis: Article 17.1 MAR - confidentialinformation

Management Board of Medicalgorithmics S.A.headquarted in Warsaw (hereinafter the _quot;Company_quot;) with reference to theCompany's report no. 1/2023, announces that on January 16th, 2023,Medicalgorithmics US Holding Corporation (hereinafter "Holding")received from Medi-Lynx Cardiac Monitoring (hereinafter "Medi-Lynx") 3.0mUSD as the IRS tax refund (as referred to in report no. 47/2022)._#160;The amount received was transferred to theCompany as Repayment of Holding's liabilities.

Management Board the Company with reference to theCompany's report no. 1/2023 reminds that the tax refund amount was notincluded in Company's financial plan, and it will additionallysignificantly increase cash reserves to nearly 39 mPLN.

Therefore, the increased funds held by the Companywill allow the Company to accelerate the implementation of the StrategicInitiatives outlined in the Presentation of Biofund investment inMedicalgorithmics published in the current report no. 58/2022,especially executing on the new technology roadmap. It will alsoaccelerate long-term sales growth in the US and Global (OUS) markets asper the current report no. 72/2022.